BILL vs RCUS · rev $1.65B vs rev $258.0M
Bill Com Holdings Inc (BILL) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
BILL currently screens at market cap $4.78B. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the BILL and RCUS stock pages for the full models.
Not investment advice.